الولايات المتحدة · وكالات وأخبار لحظية · PR Newswire

Perlmutter Cancer Center Taps Vivek Subbiah, MD, to Lead Early-Phase Drug Development and Rare Cancer Programs

نشره PR Newswire · الولايات المتحدة منذ 1 س

The physician-scientist helped advance landmark tumor-agnostic therapies that target cancer's genetic drivers. NEW YORK, Oct. 22, 2026 /PRNewswire/ -- NYU Langone Health today…

اقرأ المقال كاملًا على PR Newswire سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.prnewswire.com)

يستحق القراءة أيضًا

Associated Press (Business)

The Ford Foundation, one of the world’s largest grantmakers, will throw more weight behind democracy

Business Wire

Lyric Releases Framework for Measuring Healthcare Decision Intelligence Maturity in Payment Accuracy

Dow Jones Newswires

Perlmutter Cancer Center Taps Vivek Subbiah, MD, to Lead Early-Phase Drug Development and Rare Cancer Programs

مشاركة

يستحق القراءة أيضًا

The Ford Foundation, one of the world’s largest grantmakers, will throw more weight behind democracy

Lyric Releases Framework for Measuring Healthcare Decision Intelligence Maturity in Payment Accuracy

Advancing Government Intelligence: Insights From the Data and Intelligence Training Forum